https://doi.org/10.15252/emmm.202012010
I
Ismahane Belhabib
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
296
Citations
4
h-index
3
i10-index
Ismahane Belhabib is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cancer Cells and Metastasis & Peptidase Inhibition and Analysis. The author has an h-index of 4, co-authored 17 publications.
ORCID: 0000-0003-4517-7945Papers by this author
works<scp>FAK</scp> activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer
2020 · EMBO Molecular Medicine · 102 citations
Cyclic AMP-binding protein Epac1 acts as a metabolic sensor to promote cardiomyocyte lipotoxicity
2021 · Cell Death and Disease · 24 citations
https://doi.org/10.1038/s41419-021-04113-9
Unveiling FKBP7 as an early endoplasmic reticulum sentinel in pancreatic stellate cell activation, collagen remodeling and tumor progression
2025 · Cancer Letters · 4 citations
https://doi.org/10.1016/j.canlet.2025.217538
ATR inhibition potentiates FOLFIRINOX cytotoxic effect in models of pancreatic ductal adenocarcinoma by remodelling the tumour microenvironment
2024 · British Journal of Cancer · 3 citations
https://doi.org/10.1038/s41416-024-02904-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat